Cancer Centers Race to Adopt Revolutionary Infection Control Technology as CDC Elevates Concern

Story by Mod Homez

Published 09/12/24 AT 2:13:44 AM PST

Healthcare-associated infection (HAI) concerns have risen dramatically since the CDC labeled stethoscope hygiene as a critical factor in addressing disease transmission. Scientific literature proves that medical devices may be overlooked as vectors for pathogens spread through touch, disproving the assumption that hand-to-hand contact is the only cause of transmission in clinical settings. After this, stethoscopes are the main perpetrators of disease and bacteria in healthcare facilities due to frequent patient contact and ineffective hygiene methods. California-based medical device startup AseptiScope® has introduced The DiskCover System, a revolutionary technology that prevents stethoscopes from touching patients directly during exams. The company’s novel technology is being adopted by leading cancer centers in the US to safeguard some of the nation’s most vulnerable patients and tackle the issue of alcohol-resistant pathogens.

Disk covers are a new innovation to help cancer centers protect their patients.
A clean glove for the Clinician’s Third Hand.

Commonly referred to as a ‘clinician’s third hand,’ stethoscopes touch US patients over five billion times per year and are as contaminated as unwashed hands. These findings prove that infection control measures have inadequately considered the risk of medical devices such as stethoscopes. Stethoscopes were disinfected per CDC guidelines in less than 4% of encounters, and it’s very plausible that patients are exposed to pathogens during every hospital visit.

Past guidelines have misclassified stethoscopes as a “non-critical” concern, but accrued evidence has shown just the opposite, with experts in the field calling on the CDC to elevate the stethoscope to a concern as significant as clinicians’ hands. In response, this year, the CDC has issued that stethoscopes ‘transmit via touch,’ and that, like hands, hygiene should be conducted between every patient exam.

However, decades of indiscriminately disinfecting with isopropyl alcohol have fueled the development of alcohol-resistant pathogens capable of surviving the recommended 60 seconds of cleaning. Leading experts in major cancer centers have called for novel solutions to this rapidly growing safety concern and updates in the CDC’s guidelines. Disposable stethoscope diaphragms have been proposed as a mitigation strategy to reduce pathogen transmission.

A new technology, The DiskCover System, has demonstrated immediate resolution to stethoscope contamination and transmission. This cutting-edge system is more effective than previously suggested disinfection methods. The DiskCover System eliminates the shortcomings of stethoscope hygiene by eliminating direct contact between the stethoscope and the patient, so that each exam is completely clean, and patients have no exposure to dangerous pathogens during examination.

Recently, experts at the top cancer centers in the U.S. called for stethoscope hygiene to become a prioritized “new normal” and, compared the data associated with all options for hygiene, their conclusion was that The DiskCover System’s aseptic, touch-free barriers are superior across a wide range of considerations. Most significantly, because they provide an “aseptic point of contact 100% of the time,” which elevates patient safety to a new level.

In Houston, the cancer care leader MD Anderson Cancer Center held its annual emergencies in oncology conference, where several abstracts were presented on the subject of stethoscope contamination. One of these publications, entitled “stethoscopes no longer need to touch patients,” received great interest from cancer experts in attendance.“The DiskCover System was created to address this major patient safety issue, and we have designed it to be easy, convenient, and immediate. Most importantly, it was designed to completely halt the transmission of pathogens and elevate patient safety during examinations,” says Scott Mader, CEO at San Diego-based AseptiScope®.

“Cancer patients are more susceptible to infection due to their course of treatment, stethoscope exams, and routine in patient assessment,” said Gerardo Midence, MD, an oncologist at the St. Joseph Cancer Center in Lewiston, Idaho. “We evaluated The DiskCover System and found it useful, practical, and functional. Importantly, it makes stethoscope hygiene more reliable and timely.” The DiskCover System is being placed in hand hygiene stations, where healthcare providers are already trained to stop before seeing the patient. For this reason, it’s no surprise that it is preferred by clinicians who rely on stethoscopes – because of their high-fidelity, time-saving nature.

The DiskCover System is also elevating patient experience, as it is a visible indicator of protection. In a study by investigators at the world-leading Cleveland Clinic, patients reported that they rarely see stethoscopes being cleaned and immediately feel The DiskCover System is a robust measure keeping them safe during exams. Five thousand miles to the west, Dr. Eric Crawley, a specialist at Hawaii Pacific Health, doesn’t need the study to see the impact on patient satisfaction. “I use this every single day, on every single patient, and, without fail, patients are blown away by it. They are incredibly impressed by our commitment to their safety. I deal with a considerable number of transplants, immuno-suppressed patients, and people that don’t need to pick up resistant pathogens.”

Immunocompromised patients, such as those undergoing cancer treatment, can visibly see the additional layer of protection added by The DiskCover System.
The DiskCover System is a visible form of patient protection.

Healthcare-associated infection (HAI) concerns have risen dramatically since the CDC labeled stethoscope hygiene as a critical factor in addressing disease transmission. Scientific…

In a post-COVID era where patients are increasingly concerned about cleanliness in clinical environments, the need for transparent, reliable, and effective infection control measures has never been more critical. Medical literature has long recognized the severity of pathogen transmission through stethoscopes, and providers are beginning to join this movement in light of changing guidelines. As breakthrough technology like the DiskCover System enables touch-free diagnostic experiences, patients can rest easy knowing that providers are committed to reducing healthcare-associated infection, preventing the growth of highly resistant pathogens to protect them in every way possible.

______________________________________________________________________________

Article from MSN Microsoft Start: https://www.msn.com/en-us/health/other/cancer-centers-race-to-adopt-revolutionary-infection-control-technology-as-cdc-elevates-concern/ar-AA1qryPI?ocid=socialshare#

AseptiScope’s The DiskCover System Featured in IBT Media International Business Times

In The War Against Dangerous Pathogens In Hospitals, Healthcare Providers Elevate Patient Safety With Simple Solutions

Created by Karcy Noonan
Published 07/30/24 AT 11:30 AM EDT

Medical staff take care of a patient in the COVID-19 intensive care unit of the Robert Bosch hospital in Stuttgart
(Photo: AFP / THOMAS KIENZLE)

A New Strategy to Protect Our Patients from Superbugs

In the autumn of 2019, at the largest infectious disease forum in the US, a group of medical experts met to discuss the challenge of Healthcare Associated Infection (HAI), which each year takes the lives of 100,000 US patients and costs providers billions of dollars. “We need a new strategy to protect our patients,” stated Frank Peacock, a widely published expert in infection control. and emergency medicine physician in Houston, Texas. Just a few months later, the world would come to a screeching halt with the greatest pandemic of the 21st century. Like all clinicians, Peacock would be thrown headfirst into a multi-year nightmare of long shifts, filled hospitals, and limited resources. The rest is of historical record.

Today, Frank Peacock still treats patients but is also the Chief Medical Officer at AseptiScope®, the company he co-founded with innovation experts who have produced novel solutions in areas like diabetes and cardiovascular disease for decades. “The greatest concern of HAI is that the bugs are winning” Peacock laments. Ever since the germ theory of disease became widely accepted in the late 19th century, clinicians have used various chemicals to kill pathogens, such as alcohol and antibiotics. However, these microorganisms are genetically diverse and are constantly evolving to survive against environmental pressures. This has led to the emergence of multidrug-resistant organisms, also known as “superbugs.” “We can’t wash our way out of this problem as these species learn to survive in the face of antimicrobials like alcohol. Recently, the CDC has elevated concerns that the stethoscope may be transmitting dangerous pathogens by touch between every patient. Touching US patients over 5 billion times a year, the stethoscope may be undermining patient safety. AseptiScope’s innovative solution, The DiskCover® System, blocks stethoscope transmission without contributing to increasing pathogen resistance” explains Peacock.

Resolving Unmet Challenges in Healthcare

AseptiScope CEO Scott Westhaver Mader uses a process he calls “Market-Driven Science,” to identify critical attributes required to resolve unmet challenges in healthcare. “Superbugs take the greatest toll on human life, so fighting them requires technologies that address both immediate needs and long-term impacts,” says Mader. “This touch-free technology provides clean patient contact, breaking transmission without evolving resistant species. Through the development of The DiskCover System, healthcare can win three battles in the war against microbes: improving patient safety, reducing the indiscriminate use of alcohol, and transitioning to sustainable technology.”

Having completed their design, development, and validation programs, co-founder and Chief Operations Officer Kelly Powers has led the operationalizing of the company. The first touch-free stethoscope hygiene system, The DiskCover System, is now registered with the FDA and the company is licensed to manufacture. “As anticipated, each production lot is bigger than the last. Our goal now is to sophisticate our approach to manufacturing as we expand our customer base and prepare to scale production for healthcare providers across the nation, who now finally have a true solution to this problem,” says Powers.

Authorities in Infection Control Recognize the Importance of Stethoscope Hygiene

The company now has attracted the attention of leaders in the field, some of the largest healthcare providers in the U.S., and a growing number of community hospitals and clinics. Top experts in infection control and patient care have recently called on the CDC to elevate the guidelines for stethoscope hygiene to the same level as hand hygiene, referring to the stethoscope as “the clinician’s third hand.” The authorities in infection control and medicine broadly have understood the nature of the problem with stethoscope transmission, but they lacked a true solution for this problem. “Now that The DiskCover System has been validated and is in use around the country, these experts are energized about resolving these patient safety challenges that have been suspected for decades and are now understood to be very real”, says Dr. Peacock. The CDC is issuing new 2024 guidelines designed to reduce the transmission of pathogens in healthcare, and with a completed framework requiring stethoscope hygiene between each patient encounter similar to hand hygiene.

“The DiskCover System is designed to block pathogen transmission while offering ease of use, workflow compatibility, sustainability, and a strong return on investment.” continues Mader. “We conduct studies published in our online clinical library, along with data showing clinical satisfaction data in hospitals, clinics, and more.”

AseptiScope, Inc. (www.aseptiscope.com) is a privately funded San Diego, California-based, clinical innovation portfolio company. AseptiScope, DiskCover, and associated logos are registered trademarks of AseptiScope, Inc.

______________________________________________________________________________

Article from International Business Times: https://www.ibtimes.com/war-against-dangerous-pathogens-hospitals-healthcare-providers-elevate-patient-safety-simple-3738473

AseptiScope, Inc. to Present on the Emerging Growth Conference on July 18th, 2024

AseptiScope invites advisors, analysts, and other interested parties to attend this interactive presentation on the Emerging Growth Conference.

San Diego, CA, July 15th / Digital Release / — AseptiScope, Infection Prevention for Clinician and Patient (the “Company”) is pleased to announce that it has been invited to present on the Emerging Growth Conference on July 18th, 2024.

The next Emerging Growth Conference is presenting on July 18th, 2024. This live, interactive online event will give existing shareholders and the Emerging Growth community the opportunity to interact with the Company’s President & CEO, Scott Mader in real time.

Interactive Presentation

Mr. Mader will present briefly and subsequently open the floor for questions. Please submit your questions in advance to Questions@EmergingGrowth.com or ask your questions during the event and Mr. Mader will do his best to get through as many of them as possible.

AseptiScope Co-Founder & CEO, Scott Mader

Event Details and Registration

AseptiScope will be presenting at 2:20 PM Eastern time for 30 minutes.

Please register here to ensure you are able to attend the conference and receive any updates that are released:

https://goto.webcasts.com/starthere.jsp?ei=1670756&tp_key=e579348dea&sti=aseptiscope

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, http://www.YouTube.com/EmergingGrowthConference. We will release a link to that after the event.

About the Emerging Growth Conference

The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.

The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.

All sessions will be conducted through video webcasts and will take place in the Eastern time zone.

About AseptiScope, Inc.

AseptiScope, Inc. (www.aseptiscope.com), formed in early 2016, is a privately funded San Diego, California-based, clinical innovation company. The company is founded and led by clinical innovation experts, leading medical researchers and practicing physicians. The AseptiScope mission is to design, develop, manufacture and commercialize novel solutions that offer “Infection Protection for Clinician & Patient.”  The company has launched the first true and practical solution for the longstanding challenge of stethoscope contamination: The DiskCover System.  Visit www.diskcover.com for more information or https://store.aseptiscope.com to purchase directly.

The DiskCover System is a visible form of elevated protection, and makes stethoscopes touch-free for patients.

Disclosure

AseptiScope, DiskCover, and related logos are registered trademarks of AseptiScope, Inc.

Media Contact:

Name: Anthony Pham

Email: apham@aseptiscope.com

Stethoscope Hygiene Solution by AseptiScope Featured in USA TODAY

The DiskCover System saves time, requires no training, and is proven to protect patients from dangerous pathogens
The DiskCover System saves time, requires no formal training, and is proven to protect patients from dangerous pathogens

“Aseptiscope® highlights shortcomings in stethoscope hygiene and other medical instruments”

Kristen Lynch | Contributor
Published 2:51 p.m. ET Aug. 7, 2023

Since the invention of the stethoscope by Rene Laënnec in 1816, the most relied-upon diagnostic tool in modern healthcare delivery and, in popular culture, is one of the identifiers of a doctor or other medical professional. However, as early as 1972, this ubiquitous medical tool has been identified as a major vector for the spread of pathogens, as the diaphragm frequently comes into contact with people, and it is not sanitized as often as it should, as opposed to strict hand hygiene protocols. Even during the COVID-19 pandemic, a study has found that stethoscopes were disinfected per CDC guidelines in less than 4% of encounters and were not disinfected at all in 82% of encounters. 

The stethoscope’s frequent use, estimated at around 5 billion times a year in the US, and its involvement in healthcare-associated infection has earned it the reputation as “the clinician’s third hand”. Because it is so frequently used, it is quite inconvenient to sterilize it after each and every use. Two ways of getting around this also present their disadvantages, as disposable stethoscopes are wasteful and costly, while using alcohol is time-consuming and may promote the growth of alcohol-resistant bacteria.  

Scott W. Mader, co-founder and CEO of medical innovation startup Aseptiscope®, says this situation has led him to realize that infection control in the medical field remains very poor, and that it has failed to innovate for many decades. In most general medical settings, the protocol remains slathering alcohol over most surfaces, and grabbing a pair of gloves that are stuffed into a tissue box. He believes that this is very primitive relative to what things should be, which is the use of the aseptic technique, the gold standard for infection control. While PPE like non-sterile gloves, masks, and alcohol gel – so prioritized during the pandemic- is designed to protect medical practitioners, aseptic measures are designed to protect the patient.     

However, aseptic technique is a time-consuming and painstaking process. After sterilizing something, it is quite difficult to deliver it somewhere else without contaminating it in any way. Surgery preparation, for example, is a very meticulous process, and its standards cannot be reasonably applied in day-to-day healthcare. This is despite healthcare-associated infections in the US causing almost 100,000 deaths and costing the health system around $40 billion each year

Even before the pandemic, Mader and his cofounders were looking to address this problem, and they engaged infection control experts to identify their pain points. This led to Aseptiscope creating the DiskCover® System, which provides a touch-free, near-instantaneous way for clinicians to apply a single-use, disk cover barrier on their stethoscope, acting as a glove for the clinician’s third hand. Each disk cover is durable and produced aseptically in Aseptiscope’s clean room. It is acoustically invisible, meaning that it has no effect on the sound quality of the stethoscope, and it has a peel-off tab for easy removal. 

The disks are dispensed through a touch-free, wall-mounted dispenser with motion sensors. The process, which takes only roughly a second, is activated by the stethoscope user by waving their hand under the dispenser and then placing the stethoscope’s diaphragm into the dispenser’s port to apply the disk. The dispenser is loaded with an easily replaceable Clean Cassette®, which contains 420 disks and preserves them in an aseptic environment until it is applied to a stethoscope.  

“One of the greatest stumbling blocks of innovation is that people are resistant to change, and healthcare professionals are no exception. In developing the DiskCover system, we made it as non-disruptive as possible to the established workflow and with minimal added cost to healthcare providers,” Mader says. 

A survey by Aseptiscope showed that more than 95% of clinicians said that the DiskCover system was easy to use, that it had a neutral or favorable impact on workflow, and that it will improve stethoscope hygiene compliance and patient safety. 

Aseptiscope was founded in 2016, and Mader says the pandemic definitely affected the company’s ability to launch the DiskCover System, with lockdown mandates and supply chain issues plaguing startups, threatening to bring the project down. The company’s leadership team is composed of clinical innovation experts, medical researchers, and practicing physicians, and it develops and validates its products through an evidence-based process. This is unlike many other devices that emerged during the pandemic that promised to help prevent infection, but were unable to demonstrate efficacy during controlled trials. 

CEO, inventor, and cofounder Scott W. Mader, who led a team of futurists in developing the first touch-free, barrier delivery system
CEO, inventor, and cofounder Scott W. Mader, who led a team of futurists in developing the first touch-free, barrier delivery system

Mader likens the pandemics’ impact on infection control to the impact 9/11 had on terrorism. “9/11 forever elevated global vigilance on international terrorism, and, the same can be said for the influence of COVID-19 on society’s vigilance against infection, where we were provided a wake-up call on our vulnerability to infection” 

Moving forward, Aseptiscope is looking to develop solutions similar to the DiskCover system for other medical devices that often come in contact with patients, such as ultrasound probes, which are all vectors for healthcare-associated infection.  

“At Aseptiscope, we use a method called market-driven science in all the products that we initiate and develop. We actually produce solutions based on what the market tells us they need, and these are designed, vetted, and validated using peer-reviewed literature on infectious diseases. This allows customers to adopt innovation based on clear evidence, versus hyperbole” Mader says.  

______________________________________________________________________________

Read the article directly from USA TODAY:

https://www.usatoday.com/story/special/contributor-content/2023/08/07/aseptiscope-highlights-shortcomings-in-stethoscope-hygiene/70544870007/